Definium Therapeutics vs Option Care Health

Definium Therapeutics (DFTX), health care, and Option Care Health (OPCH), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Option Care Health is worth $4.7B on the stock market and Definium Therapeutics $4B: Option Care Health is valued at 18% more. Over the past year Definium Therapeutics's share price has moved +164% and Option Care Health's +12.1%.

Key facts

Definium Therapeutics market value
$4B
Option Care Health market value
$4.7B
Option Care Health P/E
22.9
Option Care Health revenue
$5.6BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Definium Therapeutics vs Option Care Health: every measure side by side
Measure Definium Therapeutics Option Care Health
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$4Blower$4.7Bhigher
Revenue—$5.6B
Earnings-$183.8Mlower$207.6Mhigher
Employees105lower6,528higher
Total assets$440.1Mlower$3.5Bhigher
Valuation
P/E—22.9
P/S—0.8
P/B4.2higher3.6lower
Dividend yield0.00%0.00%
Profitability
Operating margin—5.98%
Balance sheet
Net assets$332.3Mlower$1.3Bhigher
Total liabilities$107.8Mlower$2.1Bhigher
Total debt$40.6Mlower$1.2Bhigher
Cash on hand$257.8Mhigher$232.6Mlower
Price change
Today-2.59%lower-0.25%higher
1 year+164%higher+12.1%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Definium Therapeutics only (2)

Option Care Health only (1)

Percentages are each holding's share of that investor's reported portfolio. Who owns DFTX · Who owns OPCH

Further comparisons

Learn

Questions and answers

Which is bigger, Definium Therapeutics or Option Care Health?

By market value, Option Care Health is the larger: $4.7B against $4B for Definium Therapeutics.

Which has the higher dividend yield?

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

Option Care Health: $1.2B, against $40.6M for Definium Therapeutics. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Definium Therapeutics and Option Care Health?

None of the tracked superinvestors holds both in their latest 13F filing. 2 hold Definium Therapeutics and 1 holds Option Care Health.

Cite this page

Funkfolio, “Definium Therapeutics vs Option Care Health”, data as of 18 November 2026. https://funkfolio.com/compare/dftx-vs-opch

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.